| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.4 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |